<HashMap><database>biostudies-other</database><scores/><additional><submitter>Janthawornpong K</submitter><funding>NIGMS NIH HHS</funding><pagination>1816-22</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3644560</full_dataset_link><abstract>The MEP pathway, which is absent in animals but present in most pathogenic bacteria, in the parasite responsible for malaria and in plant plastids, is a target for the development of antimicrobial drugs. IspH, an oxygen-sensitive [4Fe-4S] enzyme, catalyzes the last step of this pathway and converts (E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate (HMBPP) into the two isoprenoid precursors: isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). A crucial step in the mechanism of this enzyme is the binding of the C4 hydroxyl of HMBPP to the unique fourth iron site in the [4Fe-4S](2+) moiety. Here, we report the synthesis and the kinetic investigations of two new extremely potent inhibitors of  E. coli  IspH where the OH group of HMBPP is replaced by an amino and a thiol group. (E)-4-Mercapto-3-methylbut-2-en-1-yl diphosphate is a reversible tight-binding inhibitor of IspH with K(i) = 20 ± 2 nM. A detailed kinetic analysis revealed that (E)-4-amino-3-methylbut-2-en-1-yl diphosphate is a reversible slow-binding inhibitor of IspH with K(i) = 54 ± 19 nM. The slow binding behavior of this inhibitor is best described by a one-step mechanism with the slow step consisting of the formation of the enzyme-inhibitor (EI) complex.</abstract><repository>biostudies-other</repository><data_source>Europe PMC</data_source><omics_type>Unknown</omics_type><volume>135(5)</volume><journal>Journal of the American Chemical Society</journal><pmcid>PMC3644560</pmcid><funding_grant_id>GM 25521</funding_grant_id><funding_grant_id>R01 GM025521</funding_grant_id><pubmed_authors>Janthawornpong K</pubmed_authors><pubmed_authors>Krasutsky S</pubmed_authors><pubmed_authors>Seemann M</pubmed_authors><pubmed_authors>Rohmer M</pubmed_authors><pubmed_authors>Chaignon P</pubmed_authors><pubmed_authors>Poulter CD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of IspH, a [4Fe-4S]2+ enzyme involved in the biosynthesis of isoprenoids via the methylerythritol phosphate pathway.</name><description>The MEP pathway, which is absent in animals but present in most pathogenic bacteria, in the parasite responsible for malaria and in plant plastids, is a target for the development of antimicrobial drugs. IspH, an oxygen-sensitive [4Fe-4S] enzyme, catalyzes the last step of this pathway and converts (E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate (HMBPP) into the two isoprenoid precursors: isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). A crucial step in the mechanism of this enzyme is the binding of the C4 hydroxyl of HMBPP to the unique fourth iron site in the [4Fe-4S](2+) moiety. Here, we report the synthesis and the kinetic investigations of two new extremely potent inhibitors of  E. coli  IspH where the OH group of HMBPP is replaced by an amino and a thiol group. (E)-4-Mercapto-3-methylbut-2-en-1-yl diphosphate is a reversible tight-binding inhibitor of IspH with K(i) = 20 ± 2 nM. A detailed kinetic analysis revealed that (E)-4-amino-3-methylbut-2-en-1-yl diphosphate is a reversible slow-binding inhibitor of IspH with K(i) = 54 ± 19 nM. The slow binding behavior of this inhibitor is best described by a one-step mechanism with the slow step consisting of the formation of the enzyme-inhibitor (EI) complex.</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Feb</publication><modification>2019-03-26T23:30:03Z</modification><creation>2019-03-26T23:30:03Z</creation></dates><accession>S-EPMC3644560</accession><cross_references><pubmed>23316732</pubmed><doi>10.1021/ja309557s </doi></cross_references></HashMap>